Projects

A dynamic in 3 essential acts

Projects

A dynamic in 3 essential acts

Projects

A dynamic in 3 essential acts

Producing therapeutic cannabis

For more than six years, LaFleur has been building the project to produce cannabis to pharmaceutical standards on national soil and to be able to offer it to patients.

The production of medical cannabis is done through a secure process, in a closed environment with a controlled atmosphere.

Similarly, it complies with good manufacturing practices and admits the mobilization of experts. It is therefore a real laboratory work that will require a stabilization time over the next few years with the aim of developing drugs.

Creating drugs

The production of therapeutic cannabis in France makes it possible to secure the development of drugs whose composition varies according to the therapeutic indication.

The challenge of our project is to develop pharmaceutical specialties that respond to different pathologies.

This image is a prototype. It is not a product marketed by LaFleur. Do not take into account the mentions written on it.

Supporting patients

Producing medical cannabis to develop drugs to act for the common good of patients is our project.

LaFleur invests in research to build treatments and therapeutic innovations for the benefit of patients.

Patients participate in the development of medicines by sharing their testimonials. LaFleur was itself created by an expert patient. In this sense, LaFleur promotes health democracy at every stage of the drug development process.

Producing therapeutic cannabis

Producing therapeutic cannabis

For more than six years, LaFleur has been building the project to produce cannabis to pharmaceutical standards on national soil and to be able to offer it to patients.

The production of medical cannabis is done through a secure process, in a closed environment with a controlled atmosphere.

Similarly, it complies with good manufacturing practices and admits the mobilization of experts. It is therefore a real laboratory work that will require a stabilization time over the next few years with the aim of developing drugs.

Creating drugs

Creating drugs

Capture d’écran 2020-12-22 à 20.34.49
coucou

This image is a prototype. It is not a product marketed by LaFleur. Do not take into account the mentions written on it. 

The production of therapeutic cannabis in France makes it possible to secure the development of drugs whose composition varies according to the therapeutic indication.

The challenge of our project is to develop pharmaceutical specialties that respond to different pathologies.

Supporting patients

Supporting patients

Producing medical cannabis to develop drugs to act for the common good of patients is our project. 

LaFleur invests in research to build treatments and therapeutic innovations for the benefit of patients.

 Patients participate in the development of medicines by sharing their testimonials. LaFleur was itself created by an expert patient. In this sense, LaFleur promotes health democracy at every stage of the drug development process.

error: Contenu protégé!

Nous souhaitons que les professionnels de santé qui souhaitent se renseigner sur le cannabis médical aient accès aux dernières recherches scientifiques pour aider les patients en impasse thérapeutique.

L’espace membre est exclusivement réservé aux pro de santé, nous vérifions les informations transmises.
Si votre candidature est acceptée vous recevrez un mail de confirmation avec vos codes d’accès